Nabumetone Tablet
Product Images NDC 71335-1559

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 71335-1559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a table showing the plasma concentrations of Nabumetone Active Metabolite (BMNA) at steady state after once-daily dosing of Nabumetone at 1000 mg and 2000 mg. There were 31 participants in the 1000 mg group and 12 participants in the 2000 mg group. The table also includes a chart depicting the plasma concentration of BMNA over time, with measurements taken at various intervals ranging from 2 to 48 hours.*

FDA Label Image

Label (Lbl713351559)

This appears to be the packaging information for a drug called "Relafen" manufactured by ScieGen Pharmaceuticals Inc. The package was prepackaged by Bryant Ranck, and it contains 60 tablets of 750mg strength. The NDC number is 7133515591, and the expiration date is not available as it is indicated as "EXP MM/YY". The storage temperature recommendation is between 20°-25°C (68°-77°F). There is also a caution to keep all drugs out of reach of children. The last line is a numerical code that is not immediately recognizable as anything meaningful.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the formula COOH CHgO.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.